B-Myb Represses Vascular Smooth Muscle Cell Collagen Gene Expression and Inhibits Neointima Formation After Arterial Injury

OBJECTIVES—The function of B-Myb, a negative regulator of vascular smooth muscle cell (SMC) matrix gene transcription, was analyzed in the vasculature. METHODS AND RESULTS—Mice were generated in which the human B-myb gene was driven by the basal cytomegalovirus promoter, and 3 founders were identifi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2004-09, Vol.24 (9), p.1608-1613
Hauptverfasser: Hofmann, Claudia S, Sullivan, Christopher P, Jiang, Hao-Yuan, Stone, Phillip J, Toselli, Paul, Reis, Ernane D, Chereshnev, Igor, Schreiber, Barbara M, Sonenshein, Gail E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1613
container_issue 9
container_start_page 1608
container_title Arteriosclerosis, thrombosis, and vascular biology
container_volume 24
creator Hofmann, Claudia S
Sullivan, Christopher P
Jiang, Hao-Yuan
Stone, Phillip J
Toselli, Paul
Reis, Ernane D
Chereshnev, Igor
Schreiber, Barbara M
Sonenshein, Gail E
description OBJECTIVES—The function of B-Myb, a negative regulator of vascular smooth muscle cell (SMC) matrix gene transcription, was analyzed in the vasculature. METHODS AND RESULTS—Mice were generated in which the human B-myb gene was driven by the basal cytomegalovirus promoter, and 3 founders were identified. Mice appeared to develop normally, and human B-myb was expressed in the aortas. Total B-Myb levels were elevated in aortas of adult transgenic versus wild-type (WT) animals and varied inversely with α1(I) collagen mRNA expression. However, neonatal WT and transgenic aortas displayed comparable levels of α1(I) collagen mRNA, likely resulting from elevated levels of cyclin A, which ablated repression by B-Myb. Aortic SMCs from adult transgenic animals displayed decreased α1(I) collagen mRNA levels. To examine the role of B-Myb after vascular injury, animals were subjected to femoral artery denudation, which induces SMC-rich lesion formation. A dramatic reduction in neointima formation and lumenal narrowing was observed in arteries of B-myb transgenic versus WT mice 4 weeks after injury. CONCLUSIONS—Data indicate that B-Myb, which inhibits matrix gene expression in the adult vessel wall, reduces neointima formation after vascular injury.
doi_str_mv 10.1161/01.ATV.0000139010.71779.f3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66840758</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66840758</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5072-adccd5898bf473e8bbd36bcceb27987578cf38adffa5a672621cd2da54ed757b3</originalsourceid><addsrcrecordid>eNqFkU1vEzEQhi0EoiXwF5CFBLcN_lh_cQtRWyq1IEHp1fJ6Z8kWZ53auypR_3ydJlKO-GCP7eed8fhF6AMlc0ol_UzofHFzOydlUG5IOVZUKTPv-At0SgWrq1py-bLERJlKyJqdoDc53xW-Zoy8RicFEpIbfYoev1bX2wb_hE2CnCHjW5f9FFzCv9Yxjit8PWUfAC8hBLyMIbg_MOALGACf_XvW9HHAbmjx5bDqm37M-DvEfhj7tcPnMa3duAMW3QgJL1KZexcKezel7Vv0qnMhw7vDOkO_z89ult-qqx8Xl8vFVeUFUaxyrfet0EY3Xa046KZpuWy8h4Ypo5VQ2ndcu7brnHBSMcmob1nrRA1tuW34DH3a592keD9BHu26z7405AaIU7ZS6pooof8LUmOYVtIU8Mse9CnmnKCzm1QaTltLid15ZAm1xSN79Mg-e2Q7XsTvD1WmZg3tUXowpQAfD0DxwoUuucH3-chJYpQo6AzVe-4hhvKx-W-YHiDZFbgwrnalay6JqFgJiCnbavcYxp8AyeWsLA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19928769</pqid></control><display><type>article</type><title>B-Myb Represses Vascular Smooth Muscle Cell Collagen Gene Expression and Inhibits Neointima Formation After Arterial Injury</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Hofmann, Claudia S ; Sullivan, Christopher P ; Jiang, Hao-Yuan ; Stone, Phillip J ; Toselli, Paul ; Reis, Ernane D ; Chereshnev, Igor ; Schreiber, Barbara M ; Sonenshein, Gail E</creator><creatorcontrib>Hofmann, Claudia S ; Sullivan, Christopher P ; Jiang, Hao-Yuan ; Stone, Phillip J ; Toselli, Paul ; Reis, Ernane D ; Chereshnev, Igor ; Schreiber, Barbara M ; Sonenshein, Gail E</creatorcontrib><description>OBJECTIVES—The function of B-Myb, a negative regulator of vascular smooth muscle cell (SMC) matrix gene transcription, was analyzed in the vasculature. METHODS AND RESULTS—Mice were generated in which the human B-myb gene was driven by the basal cytomegalovirus promoter, and 3 founders were identified. Mice appeared to develop normally, and human B-myb was expressed in the aortas. Total B-Myb levels were elevated in aortas of adult transgenic versus wild-type (WT) animals and varied inversely with α1(I) collagen mRNA expression. However, neonatal WT and transgenic aortas displayed comparable levels of α1(I) collagen mRNA, likely resulting from elevated levels of cyclin A, which ablated repression by B-Myb. Aortic SMCs from adult transgenic animals displayed decreased α1(I) collagen mRNA levels. To examine the role of B-Myb after vascular injury, animals were subjected to femoral artery denudation, which induces SMC-rich lesion formation. A dramatic reduction in neointima formation and lumenal narrowing was observed in arteries of B-myb transgenic versus WT mice 4 weeks after injury. CONCLUSIONS—Data indicate that B-Myb, which inhibits matrix gene expression in the adult vessel wall, reduces neointima formation after vascular injury.</description><identifier>ISSN: 1079-5642</identifier><identifier>EISSN: 1524-4636</identifier><identifier>DOI: 10.1161/01.ATV.0000139010.71779.f3</identifier><identifier>PMID: 15256398</identifier><identifier>CODEN: ATVBFA</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Age Factors ; Animals ; Animals, Newborn ; Aorta - metabolism ; Atherosclerosis (general aspects, experimental research) ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cell Cycle Proteins - biosynthesis ; Cell Cycle Proteins - genetics ; Cell Cycle Proteins - physiology ; Collagen - biosynthesis ; Collagen - genetics ; Cyclin A - biosynthesis ; Cyclin A - genetics ; Cytomegalovirus - genetics ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; DNA-Binding Proteins - biosynthesis ; DNA-Binding Proteins - genetics ; DNA-Binding Proteins - physiology ; Female ; Femoral Artery - injuries ; Femoral Artery - metabolism ; Femoral Artery - pathology ; Gene Expression Regulation ; Human cytomegalovirus ; Humans ; Male ; Medical sciences ; Mice ; Mice, Transgenic ; Muscle, Smooth, Vascular - metabolism ; Muscle, Smooth, Vascular - pathology ; Myocytes, Smooth Muscle - metabolism ; Myocytes, Smooth Muscle - pathology ; Promoter Regions, Genetic ; RNA, Messenger - biosynthesis ; Trans-Activators - biosynthesis ; Trans-Activators - genetics ; Trans-Activators - physiology ; Transgenes ; Tunica Intima - pathology</subject><ispartof>Arteriosclerosis, thrombosis, and vascular biology, 2004-09, Vol.24 (9), p.1608-1613</ispartof><rights>2004 American Heart Association, Inc.</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5072-adccd5898bf473e8bbd36bcceb27987578cf38adffa5a672621cd2da54ed757b3</citedby><cites>FETCH-LOGICAL-c5072-adccd5898bf473e8bbd36bcceb27987578cf38adffa5a672621cd2da54ed757b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16097556$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15256398$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hofmann, Claudia S</creatorcontrib><creatorcontrib>Sullivan, Christopher P</creatorcontrib><creatorcontrib>Jiang, Hao-Yuan</creatorcontrib><creatorcontrib>Stone, Phillip J</creatorcontrib><creatorcontrib>Toselli, Paul</creatorcontrib><creatorcontrib>Reis, Ernane D</creatorcontrib><creatorcontrib>Chereshnev, Igor</creatorcontrib><creatorcontrib>Schreiber, Barbara M</creatorcontrib><creatorcontrib>Sonenshein, Gail E</creatorcontrib><title>B-Myb Represses Vascular Smooth Muscle Cell Collagen Gene Expression and Inhibits Neointima Formation After Arterial Injury</title><title>Arteriosclerosis, thrombosis, and vascular biology</title><addtitle>Arterioscler Thromb Vasc Biol</addtitle><description>OBJECTIVES—The function of B-Myb, a negative regulator of vascular smooth muscle cell (SMC) matrix gene transcription, was analyzed in the vasculature. METHODS AND RESULTS—Mice were generated in which the human B-myb gene was driven by the basal cytomegalovirus promoter, and 3 founders were identified. Mice appeared to develop normally, and human B-myb was expressed in the aortas. Total B-Myb levels were elevated in aortas of adult transgenic versus wild-type (WT) animals and varied inversely with α1(I) collagen mRNA expression. However, neonatal WT and transgenic aortas displayed comparable levels of α1(I) collagen mRNA, likely resulting from elevated levels of cyclin A, which ablated repression by B-Myb. Aortic SMCs from adult transgenic animals displayed decreased α1(I) collagen mRNA levels. To examine the role of B-Myb after vascular injury, animals were subjected to femoral artery denudation, which induces SMC-rich lesion formation. A dramatic reduction in neointima formation and lumenal narrowing was observed in arteries of B-myb transgenic versus WT mice 4 weeks after injury. CONCLUSIONS—Data indicate that B-Myb, which inhibits matrix gene expression in the adult vessel wall, reduces neointima formation after vascular injury.</description><subject>Age Factors</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Aorta - metabolism</subject><subject>Atherosclerosis (general aspects, experimental research)</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cell Cycle Proteins - biosynthesis</subject><subject>Cell Cycle Proteins - genetics</subject><subject>Cell Cycle Proteins - physiology</subject><subject>Collagen - biosynthesis</subject><subject>Collagen - genetics</subject><subject>Cyclin A - biosynthesis</subject><subject>Cyclin A - genetics</subject><subject>Cytomegalovirus - genetics</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>DNA-Binding Proteins - biosynthesis</subject><subject>DNA-Binding Proteins - genetics</subject><subject>DNA-Binding Proteins - physiology</subject><subject>Female</subject><subject>Femoral Artery - injuries</subject><subject>Femoral Artery - metabolism</subject><subject>Femoral Artery - pathology</subject><subject>Gene Expression Regulation</subject><subject>Human cytomegalovirus</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Muscle, Smooth, Vascular - metabolism</subject><subject>Muscle, Smooth, Vascular - pathology</subject><subject>Myocytes, Smooth Muscle - metabolism</subject><subject>Myocytes, Smooth Muscle - pathology</subject><subject>Promoter Regions, Genetic</subject><subject>RNA, Messenger - biosynthesis</subject><subject>Trans-Activators - biosynthesis</subject><subject>Trans-Activators - genetics</subject><subject>Trans-Activators - physiology</subject><subject>Transgenes</subject><subject>Tunica Intima - pathology</subject><issn>1079-5642</issn><issn>1524-4636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1vEzEQhi0EoiXwF5CFBLcN_lh_cQtRWyq1IEHp1fJ6Z8kWZ53auypR_3ydJlKO-GCP7eed8fhF6AMlc0ol_UzofHFzOydlUG5IOVZUKTPv-At0SgWrq1py-bLERJlKyJqdoDc53xW-Zoy8RicFEpIbfYoev1bX2wb_hE2CnCHjW5f9FFzCv9Yxjit8PWUfAC8hBLyMIbg_MOALGACf_XvW9HHAbmjx5bDqm37M-DvEfhj7tcPnMa3duAMW3QgJL1KZexcKezel7Vv0qnMhw7vDOkO_z89ult-qqx8Xl8vFVeUFUaxyrfet0EY3Xa046KZpuWy8h4Ypo5VQ2ndcu7brnHBSMcmob1nrRA1tuW34DH3a592keD9BHu26z7405AaIU7ZS6pooof8LUmOYVtIU8Mse9CnmnKCzm1QaTltLid15ZAm1xSN79Mg-e2Q7XsTvD1WmZg3tUXowpQAfD0DxwoUuucH3-chJYpQo6AzVe-4hhvKx-W-YHiDZFbgwrnalay6JqFgJiCnbavcYxp8AyeWsLA</recordid><startdate>200409</startdate><enddate>200409</enddate><creator>Hofmann, Claudia S</creator><creator>Sullivan, Christopher P</creator><creator>Jiang, Hao-Yuan</creator><creator>Stone, Phillip J</creator><creator>Toselli, Paul</creator><creator>Reis, Ernane D</creator><creator>Chereshnev, Igor</creator><creator>Schreiber, Barbara M</creator><creator>Sonenshein, Gail E</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>200409</creationdate><title>B-Myb Represses Vascular Smooth Muscle Cell Collagen Gene Expression and Inhibits Neointima Formation After Arterial Injury</title><author>Hofmann, Claudia S ; Sullivan, Christopher P ; Jiang, Hao-Yuan ; Stone, Phillip J ; Toselli, Paul ; Reis, Ernane D ; Chereshnev, Igor ; Schreiber, Barbara M ; Sonenshein, Gail E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5072-adccd5898bf473e8bbd36bcceb27987578cf38adffa5a672621cd2da54ed757b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Age Factors</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Aorta - metabolism</topic><topic>Atherosclerosis (general aspects, experimental research)</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cell Cycle Proteins - biosynthesis</topic><topic>Cell Cycle Proteins - genetics</topic><topic>Cell Cycle Proteins - physiology</topic><topic>Collagen - biosynthesis</topic><topic>Collagen - genetics</topic><topic>Cyclin A - biosynthesis</topic><topic>Cyclin A - genetics</topic><topic>Cytomegalovirus - genetics</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>DNA-Binding Proteins - biosynthesis</topic><topic>DNA-Binding Proteins - genetics</topic><topic>DNA-Binding Proteins - physiology</topic><topic>Female</topic><topic>Femoral Artery - injuries</topic><topic>Femoral Artery - metabolism</topic><topic>Femoral Artery - pathology</topic><topic>Gene Expression Regulation</topic><topic>Human cytomegalovirus</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Muscle, Smooth, Vascular - metabolism</topic><topic>Muscle, Smooth, Vascular - pathology</topic><topic>Myocytes, Smooth Muscle - metabolism</topic><topic>Myocytes, Smooth Muscle - pathology</topic><topic>Promoter Regions, Genetic</topic><topic>RNA, Messenger - biosynthesis</topic><topic>Trans-Activators - biosynthesis</topic><topic>Trans-Activators - genetics</topic><topic>Trans-Activators - physiology</topic><topic>Transgenes</topic><topic>Tunica Intima - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hofmann, Claudia S</creatorcontrib><creatorcontrib>Sullivan, Christopher P</creatorcontrib><creatorcontrib>Jiang, Hao-Yuan</creatorcontrib><creatorcontrib>Stone, Phillip J</creatorcontrib><creatorcontrib>Toselli, Paul</creatorcontrib><creatorcontrib>Reis, Ernane D</creatorcontrib><creatorcontrib>Chereshnev, Igor</creatorcontrib><creatorcontrib>Schreiber, Barbara M</creatorcontrib><creatorcontrib>Sonenshein, Gail E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hofmann, Claudia S</au><au>Sullivan, Christopher P</au><au>Jiang, Hao-Yuan</au><au>Stone, Phillip J</au><au>Toselli, Paul</au><au>Reis, Ernane D</au><au>Chereshnev, Igor</au><au>Schreiber, Barbara M</au><au>Sonenshein, Gail E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>B-Myb Represses Vascular Smooth Muscle Cell Collagen Gene Expression and Inhibits Neointima Formation After Arterial Injury</atitle><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle><addtitle>Arterioscler Thromb Vasc Biol</addtitle><date>2004-09</date><risdate>2004</risdate><volume>24</volume><issue>9</issue><spage>1608</spage><epage>1613</epage><pages>1608-1613</pages><issn>1079-5642</issn><eissn>1524-4636</eissn><coden>ATVBFA</coden><abstract>OBJECTIVES—The function of B-Myb, a negative regulator of vascular smooth muscle cell (SMC) matrix gene transcription, was analyzed in the vasculature. METHODS AND RESULTS—Mice were generated in which the human B-myb gene was driven by the basal cytomegalovirus promoter, and 3 founders were identified. Mice appeared to develop normally, and human B-myb was expressed in the aortas. Total B-Myb levels were elevated in aortas of adult transgenic versus wild-type (WT) animals and varied inversely with α1(I) collagen mRNA expression. However, neonatal WT and transgenic aortas displayed comparable levels of α1(I) collagen mRNA, likely resulting from elevated levels of cyclin A, which ablated repression by B-Myb. Aortic SMCs from adult transgenic animals displayed decreased α1(I) collagen mRNA levels. To examine the role of B-Myb after vascular injury, animals were subjected to femoral artery denudation, which induces SMC-rich lesion formation. A dramatic reduction in neointima formation and lumenal narrowing was observed in arteries of B-myb transgenic versus WT mice 4 weeks after injury. CONCLUSIONS—Data indicate that B-Myb, which inhibits matrix gene expression in the adult vessel wall, reduces neointima formation after vascular injury.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>15256398</pmid><doi>10.1161/01.ATV.0000139010.71779.f3</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1079-5642
ispartof Arteriosclerosis, thrombosis, and vascular biology, 2004-09, Vol.24 (9), p.1608-1613
issn 1079-5642
1524-4636
language eng
recordid cdi_proquest_miscellaneous_66840758
source MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection
subjects Age Factors
Animals
Animals, Newborn
Aorta - metabolism
Atherosclerosis (general aspects, experimental research)
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cell Cycle Proteins - biosynthesis
Cell Cycle Proteins - genetics
Cell Cycle Proteins - physiology
Collagen - biosynthesis
Collagen - genetics
Cyclin A - biosynthesis
Cyclin A - genetics
Cytomegalovirus - genetics
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
DNA-Binding Proteins - biosynthesis
DNA-Binding Proteins - genetics
DNA-Binding Proteins - physiology
Female
Femoral Artery - injuries
Femoral Artery - metabolism
Femoral Artery - pathology
Gene Expression Regulation
Human cytomegalovirus
Humans
Male
Medical sciences
Mice
Mice, Transgenic
Muscle, Smooth, Vascular - metabolism
Muscle, Smooth, Vascular - pathology
Myocytes, Smooth Muscle - metabolism
Myocytes, Smooth Muscle - pathology
Promoter Regions, Genetic
RNA, Messenger - biosynthesis
Trans-Activators - biosynthesis
Trans-Activators - genetics
Trans-Activators - physiology
Transgenes
Tunica Intima - pathology
title B-Myb Represses Vascular Smooth Muscle Cell Collagen Gene Expression and Inhibits Neointima Formation After Arterial Injury
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T10%3A02%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=B-Myb%20Represses%20Vascular%20Smooth%20Muscle%20Cell%20Collagen%20Gene%20Expression%20and%20Inhibits%20Neointima%20Formation%20After%20Arterial%20Injury&rft.jtitle=Arteriosclerosis,%20thrombosis,%20and%20vascular%20biology&rft.au=Hofmann,%20Claudia%20S&rft.date=2004-09&rft.volume=24&rft.issue=9&rft.spage=1608&rft.epage=1613&rft.pages=1608-1613&rft.issn=1079-5642&rft.eissn=1524-4636&rft.coden=ATVBFA&rft_id=info:doi/10.1161/01.ATV.0000139010.71779.f3&rft_dat=%3Cproquest_cross%3E66840758%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19928769&rft_id=info:pmid/15256398&rfr_iscdi=true